Gene · 825
Papers1,501
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,501
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical and Genetic Characterization of CAPN3-Related Limb-Girdle Muscular Dystrophies in an Egyptian Cohort. | Pediatr Neurol | 2026 | 41633215 | PubTator, text mining | PubMed |
| Single-cell analysis reveals neuroprotective histone deacetylase inhibitor pathways. | Alzheimers Dement | 2026 | 41630642 | PubTator, text mining | PubMed |
| Silencing PAR-2 in macrophages promotes PANoptosis and triggers duodenal microinflammation in functional dyspepsia. | Int Immunopharmacol | 2026 | 41564477 | PubTator, text mining | PubMed |
| The MAD2L1-FOXM1 axis negatively regulates CD4⁺ T cell and macrophages infiltration in lung adenocarcinoma. | Discov Oncol | 2026 | 41533300 | PubTator, text mining | PubMed |
| Perinatal management of a pregnant patient with limb-girdle muscular dystrophy R1 calpain3-related. | BMJ Case Rep | 2026 | 41529897 | PubTator, text mining | PubMed |
| Pompe disease: a country-wide molecular screening in a cohort of 15,068 study participants. | Front Mol Biosci | 2025 | 41695778 | PubTator, text mining | PubMed |
| Recurrent CAPN3 p.Asp753Asn Variant Supports a Potential Dominant Calpainopathy with Variable Clinical Expressivity. | Int J Mol Sci | 2025 | 41373542 | PubTator, text mining | PubMed |
| Dantrolene-Responsive Muscle Stiffness in a Patient With a Normal Neurologic Exam and EMG: A Case Report. | Case Rep Neurol Med | 2025 | 41357548 | PubTator, text mining | PubMed |
| [Michel Fardeau, a life dedicated to myology and its innovations]. | Med Sci (Paris) | 2025 | 41313070 | PubTator, text mining | PubMed |
| Myoblast paracrine factors induce catabolic remodelling in electrically stimulated myotubes. | Sci Rep | 2025 | 41188318 | PubTator, text mining | PubMed |
| Motor Function in Limb-Girdle Muscular Dystrophy R1/2A: Validation of Clinical Outcome Assessments for Clinical Care and Trial Readiness. | Neurol Genet | 2025 | 41181282 | PubTator, text mining | PubMed |
| Clinical characteristics and genetic causes of unexplained pediatric liver disease. | World J Hepatol | 2025 | 41179737 | PubTator, text mining | PubMed |
| TRIM2 inhibits apoptosis by ubiquitinating BNIP3 to protect the intestine against ischemia-reperfusion injury in mice. | Commun Biol | 2025 | 40883557 | PubTator, text mining | PubMed |
| Clinical and Genetic Characterization of the Largest Cohort of Patients With D3 Limb-Girdle Muscular Dystrophy in an Isolated Uruguayan Population. | Eur J Neurol | 2025 | 40878969 | PubTator, text mining | PubMed |
| Genetic and Clinical Spectrum of Limb-Girdle Muscular Dystrophies in Western Sicily. | Genes (Basel) | 2025 | 40870035 | PubTator, text mining | PubMed |
| Generation of induced pluripotent stem cell lines from three LGMD R1 patients carrying CAPN3 hypomorphic intronic variant c.1746-20C > G. | Stem Cell Res | 2025 | 40834588 | PubTator, text mining | PubMed |
| Whole-exome sequencing identifies TRIM72 as a candidate gene for autosomal recessive limb-girdle muscular dystrophy. | Hum Genomics | 2025 | 40804694 | PubTator, text mining | PubMed |
| Autosomal Dominant Calpainopathy in a Diabetic Patient Complicated by Functional Gitelman Syndrome. | Case Rep Med | 2025 | 40520344 | PubTator, text mining | PubMed |
| Calpainopathy (limb-girdle muscular dystrophy type R1): clinical features, diagnostic approaches, and biotechnological treatment methods. | J Neuromuscul Dis | 2025 | 40452441 | PubTator, text mining | PubMed |
| Deciphering the regulatory networks of human male germline development from embryo to adulthood. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40409516 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/825/papers?page=2